FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Schiffman

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Geographic Areas

Costa Rica

Procedures

Concepts & Ideas

Anatomy

Cervix Uteri

Co-author Network

Publications

TOP 3
Mark Schiffman; Nicolas Wentzensen
Human papillomavirus infection and the multistage carcinogenesis of cervical cancer.
Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management.
Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Schiffman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mark Schiffman; Nicolas Wentzensen
Human papillomavirus infection and the multistage carcinogenesis of cervical cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013;22(4):553-60.
2013: Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management.
Journal of lower genital tract disease 2013;17(5 Suppl 1):S78-84.
2013: Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less.
Journal of lower genital tract disease 2013;17(5 Suppl 1):S69-77.
2013: Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years.
Journal of lower genital tract disease 2013;17(5 Suppl 1):S64-8.
2013: Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive.
Journal of lower genital tract disease 2013;17(5 Suppl 1):S56-63.
2013: Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Five-year risks of CIN 3+ and cervical cancer among women with HPV-positive and HPV-negative high-grade Pap results.
Journal of lower genital tract disease 2013;17(5 Suppl 1):S50-5.
2013: Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results.
Journal of lower genital tract disease 2013;17(5 Suppl 1):S43-9.
2013: Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results.
Journal of lower genital tract disease 2013;17(5 Suppl 1):S36-42.
2013: Hormuzd A Katki; Philip E Castle; Li C Cheung; Barbara Fetterman; Julia C Gage; Thomas Lorey; Nancy E Poitras; Tina Raine-Bennett; Mark Schiffman; Walter K Kinney
Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines.
Journal of lower genital tract disease 2013;17(5 Suppl 1):S28-35.
2013: Lisa Mirabello; Ana Cecilia Rodriguez; Mark Schiffman; Dorota Scibior-Bentkowska; Natasa Vasiljevic; Sholom Wacholder; Nicolas Wentzensen; Robert D Burk; Arpita Ghosh; Rolando Herrero; Allan Hildesheim; Attila T Lorincz
Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia.
International journal of cancer. Journal international du cancer 2013;132(6):1412-22.
2013: Ahmedin Jemal; Betsy Kohler; Lauri E Markowitz; Anne-Michelle Noone; Mona Saraiya; Debbie Saslow; Mark Schiffman; Maria J Schymura; Edgar P Simard; Meg Watson; David Yankey; Robert N Anderson; Priti Bandi; Kathleen A Cronin; Christina Dorell; Christie R Eheman; S Jane Henley; Brenda K Edwards
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.
Journal of the National Cancer Institute 2013;105(3):175-201.
2013: Jill Koshiol; Mark Schiffman; Mark E Sherman; Joan L Walker; Sophia S Wang; Richard A Allen; S Terence Dunn; Michael A Gold; Roy Zhang; Rosemary E Zuna; Nicolas Wentzensen
Reproducibility of linear array for human papillomavirus genotyping.
Journal of clinical microbiology 2013;51(2):625-8.
2013: Patricia Luhn; Cara Mathews; Mark Schiffman; Katherine Smith; Joan Walker; Sophia Wang; Richard A Allen; S Terence Dunn; Michael A Gold; Roy Zhang; Rosemary E Zuna; Nicolas Wentzensen
The role of co-factors in the progression from human papillomavirus infection to cervical cancer.
Gynecologic oncology 2013;128(2):265-70.
2013: Long Fu Xi; Zhonghu He; Ayaka Hulbert; Yang Ke; Laura A Koutsky; Shu-Kuang Lee; Mark Schiffman; Rachel L Winer; Nancy B Kiviat
Persistence of newly detected human papillomavirus type 31 infection, stratified by variant lineage.
International journal of cancer. Journal international du cancer 2013;132(3):549-55.
2013: Shih-Wen Lin; Sarah C Markt; Katie Matys; Ariane Meuree; Ligia A Pinto; Carolina Porras; Wim Quint; Ana Cecilia Rodriguez; Mahboobeh Safaeian; Mark Schiffman; Leen-Jan van Doorn; Sholom Wacholder; Nicolas Wentzensen; Mark T Esser; Arpita Ghosh; Paula Gonzalez; Rolando Herrero; Allan Hildesheim; Troy J Kemp
HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays.
PloS one 2013;8(1):e53067.
2013: Nicolas Wentzensen; Hannah P Yang; Roy Zhang; Rosemary E Zuna; R Andy Allen; S Terence Dunn; Michael A Gold; Mark Schiffman; Mark Sherman; Joan Walker; Sophia S Wang
Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management.
International journal of cancer. Journal international du cancer 2013;132(1):148-54.
2012: Julia C Gage; Martha Hutchinson; Mary Reilly; Akinfolarin C Adepiti; Kayode O Ajenifuja; Laura Bell; Robert D Burk; Philip E Castle; Paul S Eder; Claire Eklund; Niwashin Shrestha; Mark Stoler; Sholom Wacholder; Nicolas Wentzensen; Mark Schiffman
Effectiveness of a simple rapid human papillomavirus DNA test in rural Nigeria.
International journal of cancer. Journal international du cancer 2012;131(12):2903-9.
2012: Megan A Clarke; Arpita Ghosh; Ariana Harari; Attila Lorincz; Lisa Mirabello; Mark Schiffman; Sholom Wacholder; Nicolas Wentzensen; Robert D Burk
Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(12):2125-37.
2012: Long Fu Xi; Victor Defilippis; Ayaka Hulbert; Laura A Koutsky; Shu-Kuang Lee; Mark Schiffman; Zhenping Shen; Nancy B Kiviat
Association of human papillomavirus type 31 variants with risk of cervical intraepithelial neoplasia grades 2-3.
International journal of cancer. Journal international du cancer 2012;131(10):2300-7.
2012: Felipe A Castro; Corey DelVecchio; Paula Gonzalez; Rolando Herrero; Allan Hildesheim; Silvia Jimenez; Hormuzd A Katki; Aimée R Kreimer; Douglas R Lowy; Carolina Porras; Wim Quint; Ana Cecilia Rodriguez; Mark Schiffman; John Schiller; Diane Solomon; Linda Struijk; Leen-Jan van Doorn; Sholom Wacholder
Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica.
The Journal of infectious diseases 2012;206(7):1103-10.
2012: Mahboobeh Safaeian; Mark Schiffman; Mark E Sherman; Leen-Jan van Doorn; Sholom Wacholder; Nicolas Wentzensen; Mark Esser; Arpita Ghosh; Paula Gonzalez; Rolando Herrero; Troy Kemp; Shih-Wen Lin; Katie Matys; Ariane Meuree; Ligia A Pinto; Carolina Porras; Wim Quint; Ana Cecilia Rodriguez; Allan Hildesheim
Direct comparison of HPV16 serological assays used to define HPV-naïve women in HPV vaccine trials.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(9):1547-54.
2012: Debbie Saslow; Mark Schiffman; Diane Solomon; Mark Spitzer; Mark H Stoler; Alan G Waxman; Nicolas Wentzensen; David C Wilbur; Joanna M Cain; Philip E Castle; David Chelmow; Levi S Downs; Eduardo L Franco; Francisco A R Garcia; W Lawson Herschel; Abbe Herzig; Maureen Killackey; Jane J Kim; Walter Kinney; Shalini L Kulasingam; Herschel W Lawson; Ann T Moriarty; Anna-Barbara Moscicki; Evan R Myers; Jeffrey Waldman
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
Journal of lower genital tract disease 2012;16(3):175-204.
2012: Aimée R Kreimer; Carolina Porras; Mark Schiffman; Mark E Sherman; Li Cheung; Franklin Demuth; Paula González; Rolando Herrero; Allan Hildesheim; Concepción Bratti; Robert D Burk; Ana Cecilia Rodríguez
Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment.
International journal of cancer. Journal international du cancer 2012;131(1):211-8.
2012: Debbie Saslow; Mark Schiffman; Diane Solomon; Mark Spitzer; Mark H Stoler; Alan G Waxman; Nicolas Wentzensen; David C Wilbur; Joanna Cain; Philip E Castle; Levi S Downs; Eduardo L Franco; Francisco A R Garcia; Maureen Killackey; Shalini L Kulasingam; Herschel W Lawson; Ann T Moriarty; Anna-Barbara Moscicki; Evan R Myers
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
CA: a cancer journal for clinicians 2012;62(3):147-72.
2012: Julia C Gage; Joe Harford; Martha Hutchinson; Mary Reilly; Akinfolarin C Adepiti; Kayode O Ajenifuja; Robert D Burk; Claire Eklund; Amr S Soliman; Sholom Wacholder; Nicolas A Wentzensen; Mark Schiffman
The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies.
International journal of cancer. Journal international du cancer 2012;130(9):2111-7.
2012: Carolina Porras; Ana Cecilia Rodríguez; Mario Alfaro; Robert D Burk; Rolando Herrero; Allan Hildesheim; Martha Hutchinson; Jorge Morales; Mark E Sherman; Diane Solomon; Sholom Wacholder; Nicolas Wentzensen; Mark Schiffman
Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy.
International journal of cancer. Journal international du cancer 2012;130(8):1879-87.
2012: Lisa Mirabello; Ana Cecilia Rodriguez; Mark Schiffman; Chang Sun; Sholom Wacholder; Nicolas Wentzensen; Arpita Ghosh; Rolando Herrero; Allan Hildesheim; Attila Lorincz; Robert D Burk
Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population.
Journal of the National Cancer Institute 2012;104(7):556-65.
2012: Debbie Saslow; Mark Schiffman; Diane Solomon; Mark Spitzer; Mark H Stoler; Alan G Waxman; Nicolas Wentzensen; David C Wilbur; Joanna Cain; Philip E Castle; Levi S Downs; Eduardo L Franco; Francisco A R Garcia; Maureen Killackey; Shalini L Kulasingam; Herschel W Lawson; Ann T Moriarty; Anna-Barbara Moscicki; Evan R Myers
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
American journal of clinical pathology 2012;137(4):516-42.
2012: Benjamin C Smith; Shankar Viswanathan; David M Barris; Philip Castle; Zigui Chen; Ariana Harari; Rolando Herrero; Thomas McAndrew; Ana Cecilia Rodriguez; Mark Schiffman; Robert D Burk
The cervical microbiome over 7 years and a comparison of methodologies for its characterization.
PloS one 2012;7(7):e40425.
2012: Mahboobeh Safaeian; Mark Schiffman; Mark E Sherman; Sholom Wacholder; Kai Yu; Laurie Burdette; Robert D Burk; STEPHEN CHANOCK; Paula Gonzalez; Rolando Herrero; Allan Hildesheim; Qizhai Li; Carolina Porras; Ana Cecilia Rodriguez; Sophia S Wang
Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer.
PloS one 2012;7(4):e33619.
2012: Megan A Clarke; Julia C Gage; Rolando Herrero; Allan Hildesheim; Ana Cecilia Rodriguez; Robert D Burk; Sholom Wacholder; Mark Schiffman
A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection.
BMC infectious diseases 2012;12():33.
2012: Hannah P Yang; Roy Zhang; Rosemary E Zuna; Richard A Allen; S Terence Dunn; Michael A Gold; Lisa M Landrum; Rodney Long; Katherine Moxley; Mark Schiffman; Mark E Sherman; Joan L Walker; Sophia S Wang; Nicolas Wentzensen
Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3.
PloS one 2012;7(1):e29051.
2012: Julia C Gage; Randi Kail; Walter Kinney; Brandon J Lamere; Thomas Lorey; Mark Sadorra; Mark Schiffman; Carrie Aldrich; Philip E Castle; Barbara Fetterman
Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests.
Journal of clinical microbiology 2012;50(1):61-5.
2011: Julia C Gage; Patti Gravitt; Edward E Partridge; Alfio Rausa; Isabel Scarinci; Mark Schiffman; Sholom Wacholder; Philip E Castle
Comparative performance of human papillomavirus DNA testing using novel sample collection methods.
Journal of clinical microbiology 2011;49(12):4185-9.
2011: Aimée R Kreimer; Douglas Lowy; Carolina Porras; Wim Quint; Ana Cecilia Rodriguez; Mark Schiffman; John T Schiller; John E Schussler; Mark E Sherman; Diane Solomon; Sholom Wacholder; Paula González; Rolando Herrero; Allan Hildesheim; Silvia Jiménez
Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine.
Journal of the National Cancer Institute 2011;103(19):1444-51.
2011: Rolando Herrero; Allan Hildesheim; Silvia Jiménez; Aimée R Kreimer; Douglas R Lowy; Carolina Porras; Wim Quint; Ana Cecilia Rodríguez; Mark Schiffman; John T Schiller; John E Schussler; Mark E Sherman; Diane Solomon; Sholom Wacholder; Paula González
Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica.
Cancer discovery 2011;1(5):408-19.
2011: Sarah E Coseo; Lori E Dodd; Paula Gonzalez; Rolando Herrero; Allan Hildesheim; Silvia Jimenez; Carolina Porras; Wim Quint; Ana Cecilia Rodriguez; Mahboobeh Safaeian; Mark Schiffman; Mark E Sherman; Diane Solomon; Leen-Jan van Doorn; Sholom Wacholder; Catherine Bougelet
Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure.
Sexually transmitted diseases 2011;38(10):976-82.
2011: Mark Schiffman; Julia C Gage; Megan A Clarke
Accepting the universal truths of cervical human papillomavirus epidemiology in pursuit of the remaining mysteries.
Sexually transmitted diseases 2011;38(10):907-8.
2011: Aimée R Kreimer; Douglas R Lowy; Carolina Porras; Wim Quint; Ana Cecilia Rodriguez; Mark Schiffman; John T Schiller; Diane Solomon; Linda Struijk; Leen-Jan van Doorn; Sholom Wacholder; Sabrina Chen; Paula González; Rolando Herrero; Allan Hildesheim; Silvia Jiménez; Hormuzd A Katki
Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial.
The lancet oncology 2011;12(9):862-70.
2011: Salvatore Vaccarella; Ana Cecilia Rodriguez; Mark Schiffman; Robert D Burk; Silvia Franceschi; Rolando Herrero; Allan Hildesheim; Martyn Plummer
Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica.
The Journal of infectious diseases 2011;204(3):385-90.
2011: Hormuzd A Katki; Walter K Kinney; Thomas Lorey; Nancy E Poitras; Mark Schiffman; Sholom Wacholder; Li Cheung; Franklin Demuth; Barbara Fetterman; Philip E Castle
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.
The lancet oncology 2011;12(7):663-72.
2011: Nicolas Wentzensen; Ana Cecilia Rodriguez; Raphael P Viscidi; Rolando Herrero; Allan Hildesheim; Arpita Ghosh; Jorge Morales; Sholom Wacholder; Diego Guillen; Mario Alfaro; Mahboobeh Safaeian; Robert D Burk; Mark Schiffman
A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study.
The Journal of infectious diseases 2011;204(1):94-102.
2011: Mark Schiffman; David R Scott; Mark E Sherman; Sholom Wacholder; Nicolas Wentzensen; Philip E Castle; Andrew G. Glass; Peter Kirk; Attila T Lorincz; Brenda B Rush; Greg Rydzak; Julie Buckland; Robert D Burk
A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(7):1398-409.
2011: Anil K Chaturvedi; Hormuzd A Katki; Allan Hildesheim; Ana Cecilia Rodríguez; Wim Quint; Mark Schiffman; Leen-Jan van Doorn; Carolina Porras; Sholom Wacholder; Paula Gonzalez; Mark E Sherman; Rolando Herrero
Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease.
The Journal of infectious diseases 2011;203(7):910-20.
2011: Philip E Castle; Ana Cecilia Rodríguez; Robert D Burk; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Jorge Morales; Greg Rydzak; Mark Schiffman
Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer.
The Journal of infectious diseases 2011;203(6):814-22.
2011: Mark Schiffman
The need for forward-looking decision analyses to guide cervical cancer prevention.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(2):219-20.
2011: Ana Cecilia Rodríguez; Alfonso J García-Piñeres; Allan Hildesheim; Rolando Herrero; Matthew Trivett; Marcus Williams; Ivannia Atmella; Margarita Ramírez; Maricela Villegas; Mark Schiffman; Robert D Burk; Enrique Freer; José Bonilla; Concepción Bratti; Ligia A Pinto
Alterations of T-cell surface markers in older women with persistent human papillomavirus infection.
International journal of cancer. Journal international du cancer 2011;128(3):597-607.
2011: Rosemary E Zuna; Richard A Allen; S Terence Dunn; Michael A Gold; Cara Mathews; Rebecca Shanesmith; Erin Tuller; Joan Walker; Sophia S Wang; Nicolas Wentzensen; Mark Schiffman
HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer.
Infectious agents and cancer 2011;6():19.
2011: Megan A Clarke; Julia C Gage; Akinfolarin C Adepiti; Kayode O Ajenifuja; Robert D Burk; Sholom Wacholder; Nicolas A Wentzensen; Mark Schiffman
A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria.
Infectious agents and cancer 2011;6():12.
2011: Benjamin Smith; Koenraad van Doorslaer; Sholom Wacholder; Tao Wang; Kai Yu; Zigui Chen; Rob DeSalle; Rolando Herrero; Laura Reimers; Mark Schiffman; Robert D Burk
Sequence imputation of HPV16 genomes for genetic association studies.
PloS one 2011;6(6):e21375.
2011: Zigui Chen; Rob DeSalle; Patti Gravitt; Rolando Herrero; Ann W Hsing; Vikrant V Sahasrabuddhe; Mark Schiffman; MICHEL SEGONDY; Kathryn Anastos; Robert D Burk
Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67.
PloS one 2011;6(5):e20183.
2010: Mahboobeh Safaeian; Koen Quint; Mark Schiffman; Ana Cecilia Rodriguez; Sholom Wacholder; Rolando Herrero; Allan Hildesheim; Raphael P Viscidi; Wim Quint; Robert D Burk
Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort.
Journal of the National Cancer Institute 2010;102(23):1794-804.
2010: Long Fu Xi; Laura A Koutsky; Philip E Castle; Zoe R Edelstein; Ayaka Hulbert; Mark Schiffman; Nancy B Kiviat
Human papillomavirus type 16 variants in paired enrollment and follow-up cervical samples: implications for a proper understanding of type-specific persistent infections.
The Journal of infectious diseases 2010;202(11):1667-70.
2010: Paula González; Allan Hildesheim; Ana Cecilia Rodríguez; Mark Schiffman; Carolina Porras; Sholom Wacholder; Alfonso García Piñeres; Ligia A Pinto; Robert D Burk; Rolando Herrero
Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 years.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(12):3044-54.
2010: Mahboobeh Safaeian; Carolina Porras; Mark Schiffman; Ana Cecilia Rodriguez; Sholom Wacholder; Paula Gonzalez; Wim Quint; Leen-Jan van Doorn; Mark E Sherman; Valérie Xhenseval; Rolando Herrero; Allan Hildesheim
Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.
Journal of the National Cancer Institute 2010;102(21):1653-62.
2010: Sarah Coseo; Carolina Porras; Allan Hildesheim; Ana Cecilia Rodriguez; Mark Schiffman; Rolando Herrero; Sholom Wacholder; Paula Gonzalez; Sophia S Wang; Mark E Sherman; Silvia Jimenez; Diane Solomon; Catherine Bougelet; Leen-Jan van Doorn; Wim Quint; Mahboobeh Safaeian
Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
Sexually transmitted diseases 2010;37(11):706-14.
2010: Troy J Kemp; Allan Hildesheim; Alfonso García-Piñeres; Marcus C Williams; Gene M Shearer; Ana Cecilia Rodriguez; Mark Schiffman; Robert D Burk; Enrique Freer; Jose Bonilla; Rolando Herrero; Ligia A Pinto
Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(8):1954-9.
2010: Philip E Castle; Mark Schiffman; Cosette M Wheeler; Nicolas Wentzensen; Patti Gravitt
Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(7):1675-81.
2010: Julia C Gage; Mark Schiffman; Diane Solomon; Cosette M Wheeler; Philip E Castle
Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(7):1668-74.
2010: Mark Schiffman; Nicolas Wentzensen
From human papillomavirus to cervical cancer.
Obstetrics and gynecology 2010;116(1):177-85.
2010: Mark Schiffman; Ana Cecilia Rodriguez; Zigui Chen; Sholom Wacholder; Rolando Herrero; Allan Hildesheim; Rob DeSalle; Brian Befano; Kai Yu; Mahboobeh Safaeian; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Martha Hutchinson; Diane Solomon; Philip E Castle; Robert D Burk
A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.
Cancer research 2010;70(8):3159-69.
2010: Bernal Cortés; Mark Schiffman; Rolando Herrero; Allan Hildesheim; Silvia Jiménez; Katheryn Shea; Paula González; Carolina Porras; Greivin Fallas; Ana Cecilia Rodríguez
Establishment and operation of a biorepository for molecular epidemiologic studies in Costa Rica.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(4):916-22.
2010: Ana Cecilia Rodríguez; Mark Schiffman; Rolando Herrero; Allan Hildesheim; Concepción Bratti; Mark E Sherman; Diane Solomon; Diego Guillén; Mario Alfaro; Jorge Morales; Martha Hutchinson; Hormuzd Katki; Li Cheung; Sholom Wacholder; Robert D Burk
Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.
Journal of the National Cancer Institute 2010;102(5):315-24.
2010: Mahboobeh Safaeian; Koenraad van Doorslaer; Mark Schiffman; Zigui Chen; Ana Cecilia Rodriguez; Rolando Herrero; Allan Hildesheim; Robert D Burk
Lack of heterogeneity of HPV16 E7 sequence compared with HPV31 and HPV73 may be related to its unique carcinogenic properties.
Archives of virology 2010;155(3):367-70.
2010: Delphine Maucort-Boulch; Martyn Plummer; Philip E Castle; Franklin Demuth; Mahboobeh Safaeian; Cosette M Wheeler; Mark Schiffman
Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology.
International journal of cancer. Journal international du cancer 2010;126(3):684-91.
2010: Philip E Castle; Mark Schiffman; Cosette M Wheeler; Nicolas Wentzensen; Patti Gravitt
Impact of improved classification on the association of human papillomavirus with cervical precancer.
American journal of epidemiology 2010;171(2):155-63.
2010: Carolina Porras; Christina Bennett; Mahboobeh Safaeian; Sarah Coseo; Ana Cecilia Rodríguez; Paula González; Martha Hutchinson; Silvia Jiménez; Mark E Sherman; Sholom Wacholder; Diane Solomon; Leen-Jan van Doorn; Catherine Bougelet; Wim Quint; Mark Schiffman; Rolando Herrero; Allan Hildesheim
Determinants of seropositivity among HPV-16/18 DNA positive young women.
BMC infectious diseases 2010;10():238.
2010: Sholom Wacholder; Bingshu Eric Chen; Allen Wilcox; George Macones; Paula Gonzalez; Brian Befano; Allan Hildesheim; Ana Cecilia Rodríguez; Diane Solomon; Rolando Herrero; Mark Schiffman
Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials.
BMJ (Clinical research ed.) 2010;340():c712.
2009: Nicolas Wentzensen; Rosemary E Zuna; Mark E Sherman; Michael A Gold; Mark Schiffman; S Terence Dunn; Jose Jeronimo; Roy Zhang; Joan Walker; Sophia S Wang
Accuracy of cervical specimens obtained for biomarker studies in women with CIN3.
Gynecologic oncology 2009;115(3):493-6.
2009: Rosemary E Zuna; William E Moore; Rebecca P Shanesmith; S Terence Dunn; Sophia S Wang; Mark Schiffman; Gregory L Blakey; Travis Teel
Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population.
International journal of cancer. Journal international du cancer 2009;125(11):2609-13.
2009: Mark Schiffman; Mahboobeh Safaeian; Nicolas Wentzensen
The use of human papillomavirus seroepidemiology to inform vaccine policy.
Sexually transmitted diseases 2009;36(11):675-9.
2009: Hormuzd A Katki; Sholom Wacholder; Diane Solomon; Philip E Castle; Mark Schiffman
Risk estimation for the next generation of prevention programmes for cervical cancer.
The lancet oncology 2009;10(11):1022-3.
2009: Nicolas Wentzensen; Mark Schiffman; Terence Dunn; Rosemary E Zuna; Michael A Gold; Richard A Allen; Roy Zhang; Mark E Sherman; Sholom Wacholder; Joan Walker; Sophia S Wang
Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.
International journal of cancer. Journal international du cancer 2009;125(9):2151-8.
2009: Diane Solomon; Phil Castle; Allan Hildesheim; Hormuzd A Katki; Mark Schiffman; Sholom Wacholder
HPV vaccination in women aged 24-45 years.
Lancet 2009;374(9697):1239; author reply 1239-40.
2009: Philip E Castle; Ana Cecilia Rodríguez; Robert D Burk; Rolando Herrero; Allan Hildesheim; Diane Solomon; Mark E Sherman; Jose Jeronimo; Mario Alfaro; Jorge Morales; Diego Guillén; Martha L Hutchinson; Sholom Wacholder; Mark Schiffman
Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer.
International journal of cancer. Journal international du cancer 2009;125(7):1649-56.
2009: Julia C Gage; Ana Cecilia Rodriguez; Mark Schiffman; Francisco M Garcia; Rodney L Long; Scott R Budihas; Rolando Herrero; Robert D Burk; Jose Jeronimo
Treatability by cryotherapy in a screen-and-treat strategy.
Journal of lower genital tract disease 2009;13(3):174-81.
2009: L Stewart Massad; Jose Jeronimo; Hormuzd A Katki; Mark Schiffman
The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia.
Journal of lower genital tract disease 2009;13(3):137-44.
2009: Philip E Castle; Aimée R Kreimer; Sholom Wacholder; Cosette M Wheeler; Laura A Koutsky; Greg Rydzak; Dennis W Buckman; Barry Graubard; Mark Schiffman
Influence of loop electrosurgical excision procedure on subsequent acquisition of new human papillomavirus infections.
The Journal of infectious diseases 2009;199(11):1612-20.
2009: Julia C Gage; Ana Cecilia Rodriguez; Mark Schiffman; Sydney Adadevoh; Manuel J Alvarez Larraondo; Bandit Chumworathayi; Sandra Vargas Lejarza; Luis Villegas Araya; Francisco Garcia; Scott R Budihas; Rodney Long; Hormuzd A Katki; Rolando Herrero; Robert D Burk; Jose Jeronimo
An evaluation by midwives and gynecologists of treatability of cervical lesions by cryotherapy among human papillomavirus-positive women.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(4):728-33.
2009: Allan Hildesheim; Mark Schiffman; Diane Solomon; Sholom Wacholder; Ana Cecilia Rodriguez; Rolando Herrero
Response to "Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines" by Verstraeten et al.
Vaccine 2009;27(19):2529.
2009: Mahboobeh Safaeian; Mark Schiffman; Julia Gage; Diane Solomon; Cosette M Wheeler; Philip E Castle
Detection of precancerous cervical lesions is differential by human papillomavirus type.
Cancer research 2009;69(8):3262-6.
2009: Mark Schiffman; Sholom Wacholder
From India to the world--a better way to prevent cervical cancer.
The New England journal of medicine 2009;360(14):1453-5.
2009: Carolina Porras; Ana Cecilia Rodríguez; Allan Hildesheim; Rolando Herrero; Paula González; Sholom Wacholder; Robert D Burk; Mark Schiffman
Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(3):863-5.
2009: Nicolas Wentzensen; Mark E Sherman; Mark Schiffman; Sophia S Wang
Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science.
Gynecologic oncology 2009;112(2):293-9.
2009: Philip E Castle; Ana Cecilia Rodríguez; Robert D Burk; Rolando Herrero; Sholom Wacholder; Mario Alfaro; Jorge Morales; Diego Guillen; Mark E Sherman; Diane Solomon; Mark Schiffman
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.
BMJ (Clinical research ed.) 2009;339():b2569.
2009: Mark Schiffman; Gary Clifford; Franco M Buonaguro
Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline.
Infectious agents and cancer 2009;4():8.
2009: Sophia S Wang; Rosemary E Zuna; Nicolas Wentzensen; S Terence Dunn; Mark E Sherman; Michael A Gold; Mark Schiffman; Sholom Wacholder; Richard A Allen; Ingrid Block; Kim Downing; Jose Jeronimo; J Daniel Carreon; Mahboobeh Safaeian; David Brown; Joan L Walker
Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(1):113-20.
2009: Sophia S Wang; M Concepcion Bratti; Ana Cecilia Rodríguez; Rolando Herrero; Robert D Burk; Carolina Porras; Paula González; Mark E Sherman; Sholom Wacholder; Z Elizabeth Lan; Mark Schiffman; STEPHEN CHANOCK; Allan Hildesheim
Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer.
The Journal of infectious diseases 2009;199(1):20-30.
2008: Douglas Lowy; Diane Solomon; Allan Hildesheim; John T Schiller; Mark Schiffman
Human papillomavirus infection and the primary and secondary prevention of cervical cancer.
Cancer 2008;113(7 Suppl):1980-93.
2008: Philip E Castle; Carolina Porras; Wim Quint; Ana Cecilia Rodriguez; Mark Schiffman; Patti Gravitt; Paula González; Hormuzd A Katki; Sandra Silva; Enrique Freer; Leen-Jan van Doorn; Silvia Jiménez; Rolando Herrero; Allan Hildesheim
Comparison of two PCR-based human papillomavirus genotyping methods.
Journal of clinical microbiology 2008;46(10):3437-45.
2008: Rolando Herrero; Allan Hildesheim; Ana C Rodríguez; Sholom Wacholder; Concepción Bratti; Diane Solomon; Paula González; Carolina Porras; Silvia Jiménez; Diego Guillen; Jorge Morales; Mario Alfaro; Jean Cyr; Kerrygrace Morrisey; Yenory Estrada; Bernal Cortés; Lidia Ana Morera; Enrique Freer; John Schussler; John Schiller; Douglas Lowy; Mark Schiffman
Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica.
Vaccine 2008;26(37):4795-808.
2008: Philip E Castle; J Thomas Cox; Mark Schiffman; Cosette M Wheeler; Diane Solomon
Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytology.
Obstetrics and gynecology 2008;112(3):637-45.
2008: Philip E Castle; Diane Solomon; Cosette M Wheeler; Patti Gravitt; Sholom Wacholder; Mark Schiffman
Human papillomavirus genotype specificity of hybrid capture 2.
Journal of clinical microbiology 2008;46(8):2595-604.
2008: Patti Gravitt; Mark Schiffman; Diane Solomon; Cosette M Wheeler; Philip E Castle
A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(5):1248-54.
2008: Ana Cecilia Rodríguez; Mark Schiffman; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Philip E Castle; Diane Solomon; Robert D Burk
Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.
Journal of the National Cancer Institute 2008;100(7):513-7.
2008: Philip E Castle; J Thomas Cox; Jose Jeronimo; Diane Solomon; Cosette M Wheeler; Patti Gravitt; Mark Schiffman
An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS).
Obstetrics and gynecology 2008;111(4):847-56.
2008: Julia C Gage; Mahboobeh Safaeian; Jose Jeronimo; Mark Schiffman
Spectroscopic imaging as triage test for cervical disease.
Journal of lower genital tract disease 2008;12(1):52-3.
2008: Philip E Castle; Mario Sideri; Jose Jeronimo; Diane Solomon; Mark Schiffman
Risk assessment to guide the prevention of cervical cancer.
Journal of lower genital tract disease 2008;12(1):1-7.
2008: Philip E Castle; Patti Gravitt; Diane Solomon; Cosette M Wheeler; Mark Schiffman
Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study.
Journal of clinical microbiology 2008;46(1):109-17.
2007: Patti Gravitt; Melinda Butsch Kovacic; Rolando Herrero; Mark Schiffman; Concepción Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Mark E Sherman; Sholom Wacholder; Ana Cecilia Rodriguez; Robert D Burk
High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.
International journal of cancer. Journal international du cancer 2007;121(12):2787-93.
2007: koen quint; Carolina Porras; Mahboobeh Safaeian; Paula González; Allan Hildesheim; Wim Quint; Leen-Jan van Doorn; Sandra Silva; Willem Melchers; Mark Schiffman; Ana Cecilia Rodríguez; Sholom Wacholder; Enrique Freer; Bernal Cortes; Rolando Herrero
Evaluation of a novel PCR-based assay for detection and identification of Chlamydia trachomatis serovars in cervical specimens.
Journal of clinical microbiology 2007;45(12):3986-91.
2007: Philip E Castle; Ana Cecilia Rodriguez; Carolina Porras; Rolando Herrero; Mark Schiffman; Paula Gonzalez; Allan Hildesheim; Robert D Burk
A comparison of cervical and vaginal human papillomavirus.
Sexually transmitted diseases 2007;34(11):849-55.
2007: M Margaret Pratt; Paul Sirajuddin; Miriam C Poirier; Mark Schiffman; Andrew G. Glass; David R Scott; Brenda B Rush; Ofelia A Olivero; Philip E Castle
Polycyclic aromatic hydrocarbon-DNA adducts in cervix of women infected with carcinogenic human papillomavirus types: an immunohistochemistry study.
Mutation research 2007;624(1-2):114-23.
2007: Jose Jeronimo; L Stewart Massad; Philip E Castle; Sholom Wacholder; Mark Schiffman
Interobserver agreement in the evaluation of digitized cervical images.
Obstetrics and gynecology 2007;110(4):833-40.
2007: Philip E Castle; Mario Sideri; Jose Jeronimo; Diane Solomon; Mark Schiffman
Risk assessment to guide the prevention of cervical cancer.
American journal of obstetrics and gynecology 2007;197(4):356.e1-6.
2007: Joseph D Carreon; Mark E Sherman; Diego Guillén; Diane Solomon; Rolando Herrero; Jose Jerónimo; Sholom Wacholder; Ana Cecilia Rodríguez; Jorge Morales; Martha Hutchinson; Robert D Burk; Mark Schiffman
CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2007;26(4):441-6.
2007: Patti Gravitt; Leen-Jan van Doorn; Wim Quint; Mark Schiffman; Allan Hildesheim; Andrew G. Glass; Brenda B Rush; Jared Hellman; Mark E Sherman; Robert D Burk; Sophia S Wang
Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions.
Journal of clinical microbiology 2007;45(10):3245-50.
2007: Mark Schiffman; Philip E Castle; Jose Jeronimo; Ana Cecilia Rodriguez; Sholom Wacholder
Human papillomavirus and cervical cancer.
Lancet 2007;370(9590):890-907.
2007: Diane Solomon; Mark Stoler; Jose Jeronimo; Michelle Khan; Philip Castle; Mark Schiffman
Diagnostic utility of endocervical curettage in women undergoing colposcopy for equivocal or low-grade cytologic abnormalities.
Obstetrics and gynecology 2007;110(2 Pt 1):288-95.
2007: Jose Jeronimo; L Stewart Massad; Mark Schiffman
Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type.
American journal of obstetrics and gynecology 2007;197(1):47.e1-8.
2007: S Terence Dunn; Richard A Allen; Sophia Wang; Joan Walker; Mark Schiffman
DNA extraction: an understudied and important aspect of HPV genotyping using PCR-based methods.
Journal of virological methods 2007;143(1):45-54.
2007: Ana Cecilia Rodriguez; Robert D Burk; Rolando Herrero; Allan Hildesheim; Concepción Bratti; Mark E Sherman; Diane Solomon; Diego Guillen; Mario Alfaro; Raphael P Viscidi; Jorge Morales; Martha Hutchinson; Sholom Wacholder; Mark Schiffman
The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life.
Sexually transmitted diseases 2007;34(7):494-502.
2007: Mahboobeh Safaeian; Diane Solomon; Sholom Wacholder; Mark Schiffman; Philip Castle
Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
Obstetrics and gynecology 2007;109(6):1325-31.
2007: Martyn Plummer; Mark Schiffman; Philip E Castle; Delphine Maucort-Boulch; Cosette M Wheeler
A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion.
The Journal of infectious diseases 2007;195(11):1582-9.
2007: Philip E Castle; Mark H Stoler; Diane Solomon; Mark Schiffman
The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report.
American journal of clinical pathology 2007;127(5):805-15.
2007: Mark E Sherman; Abhijit Dasgupta; Mark Schiffman; Ritu Nayar; Diane Solomon
The Bethesda Interobserver Reproducibility Study (BIRST): a web-based assessment of the Bethesda 2001 System for classifying cervical cytology.
Cancer 2007;111(1):15-25.
2007: Aimée R Kreimer; Hormuzd A Katki; Mark Schiffman; Cosette M Wheeler; Philip E Castle
Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(1):11-6.
2006: Philip E Castle; Mark Schiffman; Andrew G. Glass; Brenda B Rush; David R Scott; Sholom Wacholder; Anne Dunn; Robert D Burk
Human papillomavirus prevalence in women who have and have not undergone hysterectomies.
The Journal of infectious diseases 2006;194(12):1702-5.
2006: Alfonso J García-Piñeres; Allan Hildesheim; Rolando Herrero; Matthew Trivett; Marcus Williams; Ivannia Atmetlla; Margarita Ramírez; Maricela Villegas; Mark Schiffman; Ana Cecilia Rodríguez; Robert D Burk; Mariana Hildesheim; Enrique Freer; José Bonilla; Concepción Bratti; Jay A Berzofsky; Ligia A Pinto
Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women.
Cancer research 2006;66(22):11070-6.
2006: Cosette M Wheeler; William C Hunt; Mark Schiffman; Philip E Castle
Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer.
The Journal of infectious diseases 2006;194(9):1291-9.
2006: Rosemary E Zuna; Sophia S Wang; Mark Schiffman; Diane Solomon
Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion.
Cancer 2006;108(5):288-97.
2006: Melinda Butsch Kovacic; Philip E Castle; Rolando Herrero; Mark Schiffman; Mark E Sherman; Sholom Wacholder; Ana Cecilia Rodriguez; Martha L Hutchinson; M Concepcion Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Robert D Burk
Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.
Cancer research 2006;66(20):10112-9.
2006: Sophia S Wang; Mark E Sherman; Janet S Rader; Joseph D Carreon; Mark Schiffman; Carl Baker
Cervical tissue collection methods for RNA preservation: comparison of snap-frozen, ethanol-fixed, and RNAlater-fixation.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2006;15(3):144-8.
2006: Julia C Gage; Vivien W Hanson; Kim Abbey; Susan Dippery; Susi Gardner; Janet Kubota; Mark Schiffman; Diane Solomon; Jose Jeronimo
Number of cervical biopsies and sensitivity of colposcopy.
Obstetrics and gynecology 2006;108(2):264-72.
2006: Jose Jeronimo; Mark Schiffman
Colposcopy at a crossroads.
American journal of obstetrics and gynecology 2006;195(2):349-53.
2006: Mark E Sherman; Joseph D Carreon; Mark Schiffman
Performance of cytology and human papillomavirus testing in relation to the menstrual cycle.
British journal of cancer 2006;94(11):1690-6.
2006: Aimée R Kreimer; Richard S Guido; Diane Solomon; Mark Schiffman; Sholom Wacholder; Jose Jeronimo; Cosette M Wheeler; Philip E Castle
Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(5):908-14.
2006: Philip E Castle; Jose Jeronimo; Mark Schiffman; Rolando Herrero; Ana Cecilia Rodríguez; M Concepcion Bratti; Allan Hildesheim; Sholom Wacholder; L Rodney Long; Leif Neve; Ruth Pfeiffer; Robert D Burk
Age-related changes of the cervix influence human papillomavirus type distribution.
Cancer research 2006;66(2):1218-24.
2006: Jose Jeronimo; Rodney Long; Leif Neve; Daron Gale Ferris; Kenneth L Noller; Mark Spitzer; Sunanda Mitra; Jiangling Guo; Brian Nutter; Philip Castle; Rolando Herrero; Ana Cecilia Rodriguez; Mark Schiffman
Preparing digitized cervigrams for colposcopy research and education: determination of optimal resolution and compression parameters.
Journal of lower genital tract disease 2006;10(1):39-44.
2006: Jose Jeronimo; L Rodney Long; Leif Neve; Bopf Michael; Sameer Antani; Mark Schiffman
Digital tools for collecting data from cervigrams for research and training in colposcopy.
Journal of lower genital tract disease 2006;10(1):16-25.
2005: Philip E Castle; Joan L Walker; Mark Schiffman; Cosette M Wheeler
Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology.
International journal of cancer. Journal international du cancer 2005;117(6):1007-12.
2005: Mark Schiffman; Philip E Castle
The promise of global cervical-cancer prevention.
The New England journal of medicine 2005;353(20):2101-4.
2005: Sophia S Wang; Joan L Walker; Mark Schiffman; Diane Solomon
Evaluating the risk of cervical precancer with a combination of cytologic, virologic, and visual methods.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(11 Pt 1):2665-8.
2005: Mark Schiffman; Cosette M Wheeler; Abhijit Dasgupta; Diane Solomon; Philip E Castle
A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears.
American journal of clinical pathology 2005;124(5):722-32.
2005: Rosemary E Zuna; Sophia S Wang; Dorothy L Rosenthal; Jose Jeronimo; Mark Schiffman; Diane Solomon
Determinants of human papillomavirus-negative, low-grade squamous intraepithelial lesions in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions triage study (ALTS).
Cancer 2005;105(5):253-62.
2005: Richard S Guido; Jose Jeronimo; Mark Schiffman; Diane Solomon
The distribution of neoplasia arising on the cervix: results from the ALTS trial.
American journal of obstetrics and gynecology 2005;193(4):1331-7.
2005: Joseph D Carreon; Maureen P Martin; Allan Hildesheim; Xiaojiang Gao; Mark Schiffman; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Richard J Zaino; Mary Carrington; Sophia S Wang
Human leukocyte antigen class I and II haplotypes and risk of cervical cancer.
Tissue antigens 2005;66(4):321-4.
2005: Michelle J Khan; Mark Schiffman; Jose Jeronimo
Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India.
International journal of cancer. Journal international du cancer 2005;116(5):830-1.
2005: Alice de M Zelmanowicz; Mark Schiffman; Rolando Herrero; Alisa M Goldstein; Mark E Sherman; Robert D Burk; Patti Gravitt; Raphael P Viscidi; Peter Schwartz; Willard A Barnes; Rodrigue Mortel; Steven G Silverberg; Julie Buckland; Allan Hildesheim
Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States.
International journal of cancer. Journal international du cancer 2005;116(4):599-605.
2005: Michelle J Khan; Philip E Castle; Attila T Lorincz; Sholom Wacholder; Mark Sherman; David R Scott; Brenda B Rush; Andrew G. Glass; Mark Schiffman
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
Journal of the National Cancer Institute 2005;97(14):1072-9.
2005: Philip E Castle; Diane Solomon; Mark Schiffman; Cosette M Wheeler
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
Journal of the National Cancer Institute 2005;97(14):1066-71.
2005: Michelle J Khan; Edward E Partridge; Sophia S Wang; Mark Schiffman
Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.
Cancer 2005;104(1):61-70.
2005: Jose Jeronimo; Michelle J Khan; Mark Schiffman; Diane Solomon
Does the interval between papanicolaou tests influence the quality of cytology?
Cancer 2005;105(3):133-8.
2005: Mark Schiffman; Rolando Herrero; Rob DeSalle; Allan Hildesheim; Sholom Wacholder; Ana Cecilia Rodriguez; M Concepcion Bratti; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Martha Hutchinson; Thomas C Wright; Diane Solomon; Zigui Chen; John E Schussler; Philip E Castle; Robert D Burk
The carcinogenicity of human papillomavirus types reflects viral evolution.
Virology 2005;337(1):76-84.
2005: Sophia S Wang; Abhijit Dasgupta; Mark E Sherman; Joan L Walker; Michael A Gold; Rosemary E Zuna; Lori Sakoda; Sholom Wacholder; Mark Schiffman; Carl Baker
Towards improved biomarker studies of cervical neoplasia: effects of precolposcopic procedures on gene expression patterns.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2005;14(2):59-64.
2005: Philip E Castle; Mark Schiffman; Rolando Herrero; Allan Hildesheim; Ana Cecilia Rodriguez; M Concepcion Bratti; Mark E Sherman; Sholom Wacholder; Robert E Tarone; Robert D Burk
A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica.
The Journal of infectious diseases 2005;191(11):1808-16.
2005: Rolando Herrero; Philip E Castle; Mark Schiffman; M Concepcion Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Mark E Sherman; Sholom Wacholder; Sabrina Chen; Ana Cecilia Rodriguez; Robert D Burk
Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.
The Journal of infectious diseases 2005;191(11):1796-807.
2005: Philip E Castle; Mark Schiffman; David R Scott; Mark E Sherman; Andrew G. Glass; Brenda B Rush; John E Schussler; Sholom Wacholder; Attila T Lorincz
Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(5):1311-4.
2005: Kathleen McIntyre-Seltman; Philip E Castle; Richard S Guido; Mark Schiffman; Cosette M Wheeler
Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(5):1165-70.
2005: Mary Carrington; Sophia Wang; Maureen P Martin; Xiaojiang Gao; Mark Schiffman; Jie Cheng; Rolando Herrero; Ana Cecilia Rodriguez; Robert J Kurman; Rodrigue Mortel; Peter Schwartz; Andrew G. Glass; Allan Hildesheim
Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci.
The Journal of experimental medicine 2005;201(7):1069-75.
2005: Sophia S Wang; Mark Schiffman
Medication use, medical conditions, and the risk of human papillomavirus infection and subsequent cervical intraepithelial neoplasia 3 among women with mild cytologic abnormalities.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(2):542-5.
2005: Mark Schiffman; Michelle J Khan; Diane Solomon; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Ana Cecilia Rodriguez; M Concepcion Bratti; Cosette M Wheeler; Robert D Burk
A study of the impact of adding HPV types to cervical cancer screening and triage tests.
Journal of the National Cancer Institute 2005;97(2):147-50.
2005: Philip E Castle; Mark Schiffman; Rolando Herrero; Allan Hildesheim; Ana Cecilia Rodriguez; M Concepcion Bratti; Sholom Wacholder; Hortense Kendal; Anne M Breheny; Andrew Prior; Ruth Pfeiffer; Robert D Burk
PCR testing of pooled longitudinally collected cervical specimens of women to increase the efficiency of studying human papillomavirus infection.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(1):256-60.
2004: Philip E Castle; Mark Schiffman; Cosette M Wheeler
Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancer.
American journal of obstetrics and gynecology 2004;191(5):1590-7.
2004: Sophia S Wang; Mark Schiffman; Rolando Herrero; Joseph D Carreon; Allan Hildesheim; Ana Cecilia Rodriguez; M Concepcion Bratti; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Barbara Clayman; Robert D Burk; Raphael P Viscidi
Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica.
British journal of cancer 2004;91(7):1269-74.
2004: Tammy Shields; Louise A Brinton; Robert D Burk; Sophia S Wang; Stephanie J Weinstein; Regina G Ziegler; Yevgeniy Y Studentsov; Mary McAdams; Mark Schiffman
A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(10):1574-82.
2004: Philip E Castle; Cosette M Wheeler; Diane Solomon; Mark Schiffman; Cheri L Peyton
Interlaboratory reliability of Hybrid Capture 2.
American journal of clinical pathology 2004;122(2):238-45.
2004: Sophia S Wang; Marcus J Trunk; Mark Schiffman; Rolando Herrero; Mark E Sherman; Robert D Burk; Allan Hildesheim; M Concepcion Bratti; Tom Wright; Ana Cecilia Rodriguez; Sabrina Chen; Anja Reichert; Christina von Knebel Doeberitz; Ruediger Ridder; Magnus von Knebel Doeberitz
Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(8):1355-60.
2004: Philip E Castle; Mark Schiffman; M Concepcion Bratti; Allan Hildesheim; Rolando Herrero; Martha L Hutchinson; Ana Cecilia Rodriguez; Sholom Wacholder; Mark E Sherman; Hortense Kendall; Raphael P Viscidi; Jose Jeronimo; John E Schussler; Robert D Burk
A population-based study of vaginal human papillomavirus infection in hysterectomized women.
The Journal of infectious diseases 2004;190(3):458-67.
2004: Ana Cecilia Rodríguez; Lidia Ana Morera; Concepción Bratti; Rolando Herrero; J Thomas Cox; Jorge Morales; Mario Alfaro; Martha Hutchinson; Philip E Castle; Allan Hildesheim; Mark Schiffman
Performance of direct visual inspection of the cervix with acetic acid and magnification in a previously screened population.
Journal of lower genital tract disease 2004;8(2):132-8.
2004: Philip E Castle; Ana Cecilia Rodriguez; Frederick P Bowman; Rolando Herrero; Mark Schiffman; M Concepcion Bratti; Lidia Ana Morera; Danny Schust; Peggy A Crowley-Nowick; Allan Hildesheim
Comparison of ophthalmic sponges for measurements of immune markers from cervical secretions.
Clinical and diagnostic laboratory immunology 2004;11(2):399-405.
2004: M Concepcion Bratti; Ana Cecilia Rodríguez; Mark Schiffman; Allan Hildesheim; Jorge Morales; Mario Alfaro; Diego Guillén; Martha Hutchinson; Mark E Sherman; Claire Eklund; John E Schussler; Julie Buckland; Lidia Ana Morera; Fernando Cárdenas; Manuel Barrantes; Elmer Pérez; Thomas J Cox; Robert D Burk; Rolando Herrero
Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,.
Revista panamericana de salud pública = Pan American journal of public health 2004;15(2):75-89.
2004: Raphael P Viscidi; Mark Schiffman; Allan Hildesheim; Rolando Herrero; Philip E Castle; M Concepcion Bratti; Ana Cecilia Rodriguez; Mark E Sherman; Sophia Wang; Barbara Clayman; Robert D Burk
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(2):324-7.
2004: Thomas C Wright; Mark Schiffman; Diane Solomon; J Thomas Cox; Francisco Garcia; Sue J Goldie; Kenneth Hatch; Kenneth L Noller; Nancy Roach; Carolyn D Runowicz; Debbie Saslow
Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.
Obstetrics and gynecology 2004;103(2):304-9.
2004: Tammy Shields; Roni T Falk; Rolando Herrero; Mark Schiffman; N S Weiss; Concepción Bratti; Ana Cecilia Rodriguez; Mark E Sherman; Robert D Burk; Allan Hildesheim
A case-control study of endogenous hormones and cervical cancer.
British journal of cancer 2004;90(1):146-52.
2003: Philip E Castle; Terry M Phillips; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Ana Cecilia Rodríguez; Lidia Ana Morera; Ruth Pfeiffer; Martha L Hutchinson; Ligia A Pinto; Mark Schiffman
Immune profiling of plasma and cervical secretions using recycling immunoaffinity chromatography.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(12):1449-56.
2003: Ana Cecilia Rodríguez; Philip E Castle; Jennifer Smith; Concepción Bratti; Allan Hildesheim; Mark Schiffman; Raphael P Viscidi; Robert D Burk; R L Ashley; Xavier Castellsagué; Rolando Herrero
A population based study of herpes simplex virus 2 seroprevalence in rural Costa Rica.
Sexually transmitted infections 2003;79(6):460-5.
2003: Jose Jeronimo; Philip E Castle; Rolando Herrero; Robert D Burk; Mark Schiffman
HPV testing and visual inspection for cervical cancer screening in resource-poor regions.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2003;83(3):311-3.
2003: Philip E Castle; Allan Hildesheim; Mark Schiffman; Charlotte A Gaydos; Allison Cullen; Rolando Herrero; M Concepcion Bratti; Enrique Freer
Stability of archived liquid-based cytologic specimens.
Cancer 2003;99(5):320-2.
2003: Sophia S Wang; Mark Schiffman; Tammy Shields; Rolando Herrero; Allan Hildesheim; M Concepcion Bratti; Mark E Sherman; Ana Cecilia Rodriguez; Philip E Castle; Jorge Morales; Mario Alfaro; T Wright; S Chen; Barbara Clayman; Robert D Burk; Raphael P Viscidi
Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica.
British journal of cancer 2003;89(7):1248-54.
2003: Mark E Sherman; Sophia S Wang; Cosette M Wheeler; Laurie Rich; Patti Gravitt; Robert E Tarone; Mark Schiffman
Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(10):1038-44.
2003: Catterina Ferreccio; M Concepcion Bratti; Mark E Sherman; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Robert D Burk; Martha Hutchinson; Mario Alfaro; Mitchell D Greenberg; Jorge Morales; Ana Cecilia Rodriguez; John E Schussler; Claire Eklund; Guillermo Marshall; Mark Schiffman
A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(9):815-23.
2003: Philip E Castle; Attila T Lorincz; David R Scott; Mark E Sherman; Andrew G. Glass; Brenda B Rush; Sholom Wacholder; Robert D Burk; M Michele Manos; John E Schussler; Paul Macomber; Mark Schiffman
Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer.
Journal of clinical microbiology 2003;41(9):4022-30.
2003: Mark Schiffman; Diane Solomon
Findings to date from the ASCUS-LSIL Triage Study (ALTS).
Archives of pathology & laboratory medicine 2003;127(8):946-9.
2003: Mark Schiffman; Philip E Castle
Human papillomavirus: epidemiology and public health.
Archives of pathology & laboratory medicine 2003;127(8):930-4.
2003: Jose Jeronimo; Philip E Castle; Rolando Herrero; Mark E Sherman; M Concepcion Bratti; Allan Hildesheim; Mario Alfaro; Jorge Morales; Martha L Hutchinson; Robert D Burk; Attila Lorincz; Sholom Wacholder; Ana Cecilia Rodríguez; Mark Schiffman
Right-sided ectocervical lesions may be associated with false-negative cytology among women with histologic cervical intraepithelial neoplasia 2 or 3.
Journal of lower genital tract disease 2003;7(3):175-83.
2003: Philip E Castle; Carlos Escoffery; Julius Schachter; Carole Rattray; Mark Schiffman; Jeanne Moncada; Karlyn Sugai; Claudette Brown; Beverley Cranston; Barrie Hanchard; Joel Palefsky; Robert D Burk; Martha L Hutchinson; Howard D Strickler
Chlamydia trachomatis, herpes simplex virus 2, and human T-cell lymphotrophic virus type 1 are not associated with grade of cervical neoplasia in Jamaican colposcopy patients.
Sexually transmitted diseases 2003;30(7):575-80.
2003: Richard S Guido; Mark Schiffman; Diane Solomon; Louis Burke
Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study.
American journal of obstetrics and gynecology 2003;188(6):1401-5.
2003: Patti Gravitt; Robert D Burk; Attila T Lorincz; Rolando Herrero; Allan Hildesheim; Mark E Sherman; M Concepcion Bratti; Ana Cecilia Rodriguez; Kathy J Helzlsouer; Mark Schiffman
A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(6):477-84.
2003: Patti Gravitt; Allan Hildesheim; Rolando Herrero; Mark Schiffman; Mark E Sherman; M Concepcion Bratti; Ana Cecilia Rodriguez; Lidia Ana Morera; Fernando Cardenas; Frederick P Bowman; Keerti V Shah; Peggy A Crowley-Nowick
Correlates of IL-10 and IL-12 concentrations in cervical secretions.
Journal of clinical immunology 2003;23(3):175-83.
2003: Philip E Castle; Diane Solomon; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Ana Cecilia Rodriguez; Mario Alfaro; Martha L Hutchinson; S Terence Dunn; Jane Kuypers; Mark Schiffman
Stability of archived liquid-based cervical cytologic specimens.
Cancer 2003;99(2):89-96.
2003: Mark E Sherman; Sophia S Wang; Robert E Tarone; Laurie Rich; Mark Schiffman
Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(4):372-9.
2003: Mark Schiffman; Philip Castle
Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia.
Journal of the National Cancer Institute 2003;95(6):E2.
2003: Thomas C Wright; Mark Schiffman
Adding a test for human papillomavirus DNA to cervical-cancer screening.
The New England journal of medicine 2003;348(6):489-90.
2003: Mark Schiffman; Susanne Krüger Kjaer
Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.
Journal of the National Cancer Institute. Monographs 2003;(31):14-9.
2003: Mark E Sherman; Attila T Lorincz; David R Scott; Sholom Wacholder; Philip E Castle; Andrew G. Glass; Iwona Mielzynska-Lohnas; Brenda B Rush; Mark Schiffman
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Journal of the National Cancer Institute 2003;95(1):46-52.
2003: Debra T Silverman; Robert N Hoover; Linda Morris Brown; G Marie Swanson; Mark Schiffman; Raymond S Greenberg; Richard Hayes; Keith D Lillemoe; Janet B Schoenberg; Ann Grossbart Schwartz; Jonathan M Liff; Linda M Pottern; Joseph Fraumeni
Why do Black Americans have a higher risk of pancreatic cancer than White Americans?
Epidemiology (Cambridge, Mass.) 2003;14(1):45-54.
2002: Philip E Castle; Sholom Wacholder; Mark E Sherman; Attila T Lorincz; Andrew G. Glass; David R Scott; Brenda B Rush; Franklin Demuth; Mark Schiffman
Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women.
Cancer 2002;95(10):2145-51.
2002: Montserrat García-Closas; Julie B Herbstman; Mark Schiffman; Andrew G. Glass; Joanne F Dorgan
Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre-menopausal women.
International journal of cancer. Journal international du cancer 2002;102(2):172-8.
2002: Philip E Castle; Mark Schiffman; Robert D Burk; Sholom Wacholder; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Attila T Lorincz
Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(11):1394-9.
2002: Philip E Castle; Mark Schiffman; Patti Gravitt; Hortense Kendall; Stacy Fishman; Huali Dong; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Attila T Lorincz; John E Schussler; Robert D Burk
Comparisons of HPV DNA detection by MY09/11 PCR methods.
Journal of medical virology 2002;68(3):417-23.
2002: Mark Schiffman; Cosette M Wheeler; Philip E Castle
Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities.
The Journal of infectious diseases 2002;186(8):1169-72.
2002: Philip E Castle; Sholom Wacholder; Attila T Lorincz; David R Scott; Mark E Sherman; Andrew G. Glass; Brenda B Rush; John E Schussler; Mark Schiffman
A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.
Journal of the National Cancer Institute 2002;94(18):1406-14.
2002: Sophia S Wang; Allan Hildesheim; Xiaojiang Gao; Mark Schiffman; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Willard A Barnes; Mitchell D Greenberg; Larry McGowan; Rodrigue Mortel; Peter E Schwartz; Richard J Zaino; Andrew G. Glass; Robert D Burk; Peter Karacki; Mary Carrington
Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies.
The Journal of infectious diseases 2002;186(5):598-605.
2002: Attila T Lorincz; Philip E Castle; Mark E Sherman; David R Scott; Andrew G. Glass; Sholom Wacholder; Brenda B Rush; Patti Gravitt; John E Schussler; Mark Schiffman
Viral load of human papillomavirus and risk of CIN3 or cervical cancer.
Lancet 2002;360(9328):228-9.
2002: Diana L Schneider; Louis Burke; Thomas C Wright; Mark Spitzer; Nilanjan Chatterjee; Sholom Wacholder; Rolando Herrero; M Concepcion Bratti; Mitchell D Greenberg; Allan Hildesheim; Mark E Sherman; Jorge Morales; Martha L Hutchinson; Mario Alfaro; Attila Lörincz; Mark Schiffman
Can cervicography be improved? An evaluation with arbitrated cervicography interpretations.
American journal of obstetrics and gynecology 2002;187(1):15-23.
2002: Yevgeniy Y Studentsov; Mark Schiffman; Howard D Strickler; Gloria Y F Ho; Yuk-Ying Susana Pang; John Schiller; Rolando Herrero; Robert D Burk
Enhanced enzyme-linked immunosorbent assay for detection of antibodies to virus-like particles of human papillomavirus.
Journal of clinical microbiology 2002;40(5):1755-60.
2002: Diane Solomon; Mark Schiffman; Robert E Tarone
ASCUS LSIL Triage Study (ALTS) conclusions reaffirmed: response to a November 2001 commentary.
Obstetrics and gynecology 2002;99(4):671-4.
2002: Sophia S Wang; Allan Hildesheim; Xiaojiang Gao; Mark Schiffman; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Willard A Barnes; Mitchell D Greenberg; Larry McGowan; Rodrigue Mortel; Peter E Schwartz; Richard J Zaino; Andrew G. Glass; Robert D Burk; Peter Karacki; Mary Carrington
Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(4):419-20.
2002: Philip E Castle; Attila T Lorincz; Iwona Mielzynska-Lohnas; David R Scott; Andrew G. Glass; Mark E Sherman; John E Schussler; Mark Schiffman
Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible.
Journal of clinical microbiology 2002;40(3):1088-90.
2002: Philip E Castle; Tammy Shields; Reinhard Kirnbauer; M Michele Manos; Robert D Burk; Andrew G. Glass; David R Scott; Mark E Sherman; Mark Schiffman
Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivity.
Sexually transmitted diseases 2002;29(3):182-7.
2002: David R Scott; Bjorn Hagmar; Peter Maddox; Anders Hjerpe; Joakim Dillner; Jack Cuzick; Mark E Sherman; Mark H Stoler; Robert J Kurman; Nancy B Kiviat; M Michele Manos; Mark Schiffman
Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom.
Cancer 2002;96(1):14-20.
2002: Mark E Sherman; Mark Schiffman; J Thomas Cox
Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS).
Journal of the National Cancer Institute 2002;94(2):102-7.
2002: Mark Schiffman
How should the first abnormal pap smear in an 83-year-old woman be managed? Response 4.
Journal of lower genital tract disease 2002;6(1):50-2.
2001: Sophia S Wang; Cosette M Wheeler; Allan Hildesheim; Mark Schiffman; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Mario Alfaro; Martha L Hutchinson; Jorge Morales; Attila T Lorincz; Robert D Burk; Mary Carrington; Henry A Erlich; Raymond Apple
Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica.
The Journal of infectious diseases 2001;184(10):1310-4.
2001: Philip E Castle; S L Hillier; L K Rabe; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Robert D Burk; Ana Cecilia Rodriguez; Mario Alfaro; Martha L Hutchinson; Jorge Morales; Mark Schiffman
An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(10):1021-7.
2001: Mark E Sherman; Diane Solomon; Mark Schiffman
Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study.
American journal of clinical pathology 2001;116(3):386-94.
2001: Philip E Castle; T R Zemlo; Robert D Burk; D R Scott; Mark E Sherman; Attila T Lorincz; Robert J Kurman; Andrew G. Glass; Brenda B Rush; K L Liaw; Mark Schiffman
Cervical HPV DNA detection as a predictor of a recurrent SIL diagnosis among untreated women.
Journal of lower genital tract disease 2001;5(3):138-43.
2001: Allan Hildesheim; Rolando Herrero; Philip E Castle; Sholom Wacholder; M Concepcion Bratti; Mark E Sherman; Attila T Lorincz; Robert D Burk; Jorge Morales; Ana Cecilia Rodriguez; K Helgesen; Mario Alfaro; Martha Hutchinson; I Balmaceda; M Greenberg; Mark Schiffman
HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.
British journal of cancer 2001;84(9):1219-26.
2001: Allan Hildesheim; Mark Schiffman; Christina M Bromley; Sholom Wacholder; Rolando Herrero; A Rodriguez; M Concepcion Bratti; Mark E Sherman; U Scarpidis; Q Q Lin; M Terai; R L Bromley; K Buetow; Raymond Apple; Robert D Burk
Human papillomavirus type 16 variants and risk of cervical cancer.
Journal of the National Cancer Institute 2001;93(4):315-8.
2001: Diane Solomon; Mark Schiffman; Robert E Tarone
Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.
Journal of the National Cancer Institute 2001;93(4):293-9.
2001: KL Liaw; Allan Hildesheim; Robert D Burk; Patti Gravitt; Sholom Wacholder; M Michele Manos; David R Scott; Mark E Sherman; Robert J Kurman; Andrew G. Glass; S M Anderson; Mark Schiffman
A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types.
The Journal of infectious diseases 2001;183(1):8-15.
2000: Patricia Hartge; Richard Hayes; Douglas Reding; Mark E Sherman; Philip C Prorok; Mark Schiffman; Saundra S Buys
Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial.
American journal of obstetrics and gynecology 2000;183(5):1232-7.
2000: A E Smith; Mark E Sherman; David R Scott; S O Tabbara; L Dworkin; J Olson; J Thompson; C Faser; J Snell; Mark Schiffman
Review of the Bethesda System atlas does not improve reproducibility or accuracy in the classification of atypical squamous cells of undetermined significance smears.
Cancer 2000;90(4):201-6.
2000: Rolando Herrero; Allan Hildesheim; Concepción Bratti; Mark E Sherman; Martha Hutchinson; Jorge Morales; I Balmaceda; Mitchell D Greenberg; Mario Alfaro; Robert D Burk; Sholom Wacholder; M Plummer; Mark Schiffman
Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica.
Journal of the National Cancer Institute 2000;92(6):464-74.
2000: Mark Schiffman; Rolando Herrero; Allan Hildesheim; Mark E Sherman; M Concepcion Bratti; Sholom Wacholder; Mario Alfaro; Martha Hutchinson; Jorge Morales; Mitchell D Greenberg; Attila T Lorincz
HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.
JAMA : the journal of the American Medical Association 2000;283(1):87-93.
2000: Patti Gravitt; Cheri L Peyton; T Q Alessi; Cosette M Wheeler; François Coutlée; Allan Hildesheim; Mark Schiffman; David R Scott; Raymond Apple
Improved amplification of genital human papillomaviruses.
Journal of clinical microbiology 2000;38(1):357-61.
1999: Louise Wideroff; Mark Schiffman; P Haderer; A Armstrong; CE Greer; M Michele Manos; Robert D Burk; David R Scott; Mark E Sherman; John T Schiller; R N Hoover; R E Tarone; Reinhard Kirnbauer
Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions.
The Journal of infectious diseases 1999;180(5):1424-8.
1999: Debra T Silverman; Mark Schiffman; J Everhart; A Goldstein; Keith D Lillemoe; G Marie Swanson; Ann Grossbart Schwartz; Linda Morris Brown; Raymond S Greenberg; Janet B Schoenberg; Linda M Pottern; Robert N Hoover; Joseph Fraumeni
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer.
British journal of cancer 1999;80(11):1830-7.
1999: KL Liaw; Andrew G. Glass; M Michele Manos; CE Greer; David R Scott; Mark Sherman; Robert D Burk; Robert J Kurman; Sholom Wacholder; Brenda B Rush; D M Cadell; P Lawler; D Tabor; Mark Schiffman
Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions.
Journal of the National Cancer Institute 1999;91(11):954-60.
1999: Allan Hildesheim; Lisa M McShane; Mark Schiffman; M Concepcion Bratti; Ana Cecilia Rodriguez; Rolando Herrero; Lidia Ana Morera; F Cardenas; L Saxon; Frederick P Bowman; Peggy A Crowley-Nowick
Cytokine and immunoglobulin concentrations in cervical secretions: reproducibility of the Weck-cel collection instrument and correlates of immune measures.
Journal of immunological methods 1999;225(1-2):131-43.
1999: Montserrat García-Closas; Rolando Herrero; Concepción Bratti; Allan Hildesheim; Mark E Sherman; Lidia Ana Morera; Mark Schiffman
Epidemiologic determinants of vaginal pH.
American journal of obstetrics and gynecology 1999;180(5):1060-6.
1999: Martha L Hutchinson; D J Zahniser; Mark E Sherman; Rolando Herrero; Mario Alfaro; M Concepcion Bratti; Allan Hildesheim; Attila T Lorincz; Mitchell D Greenberg; Jorge Morales; Mark Schiffman
Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma.
Cancer 1999;87(2):48-55.
1999: Mark E Sherman; S O Tabbara; David R Scott; Robert J Kurman; Andrew G. Glass; M Michele Manos; Robert D Burk; Brenda B Rush; Mark Schiffman
"ASCUS, rule out HSIL": cytologic features, histologic correlates, and human papillomavirus detection.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1999;12(4):335-42.
1999: A Ung; T R Kramer; Mark Schiffman; Rolando Herrero; M Concepcion Bratti; Robert D Burk; Christine A Swanson; Mark E Sherman; Martha L Hutchinson; Mario Alfaro; Jorge Morales; I Balmaceda; Allan Hildesheim
Soluble interleukin 2 receptor levels and cervical neoplasia: results from a population-based case-control study in Costa Rica.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1999;8(3):249-53.
1999: Allan Hildesheim; Olympia C Hadjimichael; Peter E Schwartz; Cosette M Wheeler; Willard A Barnes; D M Lowell; J Willett; Mark Schiffman
Risk factors for rapid-onset cervical cancer.
American journal of obstetrics and gynecology 1999;180(3 Pt 1):571-7.
1999: D L Schneider; Rolando Herrero; Concepción Bratti; Mitchell D Greenberg; Allan Hildesheim; Mark E Sherman; Jorge Morales; Martha L Hutchinson; T V Sedlacek; Attila T Lorincz; LJ Mango; Sholom Wacholder; Mario Alfaro; Mark Schiffman
Cervicography screening for cervical cancer among 8460 women in a high-risk population.
American journal of obstetrics and gynecology 1999;180(2 Pt 1):290-8.
1998: Allan Hildesheim; Mark Schiffman; L A Brinton; Joseph Fraumeni; Rolando Herrero; M Concepcion Bratti; P Schwartz; Rodrigue Mortel; W Barnes; M Greenberg; Larry McGowan; D R Scott; M Martin; J E Herrera; M Carrington
p53 polymorphism and risk of cervical cancer.
Nature 1998;396(6711):531-2.
1998: Allan Hildesheim; Mark Schiffman; David R Scott; D Marti; T Kissner; Mark E Sherman; Andrew G. Glass; M Michele Manos; Attila T Lorincz; Robert J Kurman; J Buckland; Brenda B Rush; Mary Carrington
Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1998;7(11):1035-41.
1998: Cheri L Peyton; Mark Schiffman; A T Lörincz; William C Hunt; I Mielzynska; Concepción Bratti; S Eaton; Allan Hildesheim; Lidia Ana Morera; Ana Cecilia Rodriguez; Rolando Herrero; Mark E Sherman; Cosette M Wheeler
Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies.
Journal of clinical microbiology 1998;36(11):3248-54.
1998: Mark E Sherman; Mark Schiffman; Rolando Herrero; Deidra Kelly; Concepción Bratti; LJ Mango; Mario Alfaro; Martha L Hutchinson; F Mena; Allan Hildesheim; Jorge Morales; Mitchell D Greenberg; I Balmaceda; Attila T Lorincz
Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica.
Cancer 1998;84(5):273-80.
1998: Allan Hildesheim; M Concepcion Bratti; Robert P Edwards; Mark Schiffman; Ana Cecilia Rodriguez; Rolando Herrero; Mario Alfaro; Lidia Ana Morera; S V Ermatinger; B T Miller; Peggy A Crowley-Nowick
Collection of cervical secretions does not adversely affect Pap smears taken immediately afterward.
Clinical and diagnostic laboratory immunology 1998;5(4):491-3.
1998: Louise Wideroff; Nancy Potischman; Andrew G. Glass; CE Greer; M Michele Manos; David R Scott; Robert D Burk; Mark E Sherman; Sholom Wacholder; Mark Schiffman
A nested case-control study of dietary factors and the risk of incident cytological abnormalities of the cervix.
Nutrition and cancer 1998;30(2):130-6.
1998: M E Sherman; Mark Schiffman; Howard D Strickler; Allan Hildesheim
Prospects for a prophylactic HPV vaccine: rationale and future implications for cervical cancer screening.
Diagnostic cytopathology 1998;18(1):5-9.
1997: KL Liaw; A W Hsing; Mark Schiffman; S L You; T Zhang; Robert D Burk; C J Chen
Human papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women.
International journal of cancer. Journal international du cancer 1997;73(5):775-6.
1997: Allan Hildesheim; Mark Schiffman; T Tsukui; Christine A Swanson; Joseph Lucci; David R Scott; Andrew G. Glass; Brenda B Rush; Attila T Lorincz; A Corrigan; Robert D Burk; K Helgesen; R A Houghten; Mark E Sherman; Robert J Kurman; J A Berzofsky; T R Kramer
Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(10):807-13.
1997: J U Cope; Allan Hildesheim; Mark Schiffman; M Michele Manos; A T Lörincz; Robert D Burk; Andrew G. Glass; C Greer; J Buckland; K Helgesen; David R Scott; Mark E Sherman; Robert J Kurman; KL Liaw
Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens.
Journal of clinical microbiology 1997;35(9):2262-5.
1997: Mark E Sherman; Mark Schiffman; LJ Mango; Deidra Kelly; D Acosta; zelma cason; P Elgert; S Zaleski; David R Scott; Robert J Kurman; M Stoler; Attila T Lorincz
Evaluation of PAPNET testing as an ancillary tool to clarify the status of the "atypical" cervical smear.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1997;10(6):564-71.
1997: Rolando Herrero; Mark Schiffman; Concepción Bratti; Allan Hildesheim; I Balmaceda; Mark E Sherman; M Greenberg; F Cárdenas; V Gómez; K Helgesen; Jorge Morales; Martha Hutchinson; LJ Mango; Mario Alfaro; N W Potischman; Sholom Wacholder; C Swanson; L A Brinton
Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project.
Revista panamericana de salud pública = Pan American journal of public health 1997;1(5):362-75.
1997: Mark E Sherman; Mark Schiffman; Attila T Lorincz; Rolando Herrero; Martha L Hutchinson; Concepción Bratti; D Zahniser; Jorge Morales; Allan Hildesheim; K Helgesen; Deidra Kelly; Mario Alfaro; F Mena; I Balmaceda; LJ Mango; M Greenberg
Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
Cancer 1997;81(2):89-97.
1997: Howard D Strickler; Mark Schiffman; C Eklund; Andrew G. Glass; David R Scott; Mark E Sherman; Sholom Wacholder; Robert J Kurman; M Michele Manos; John T Schiller; Joakim Dillner
Evidence for at least two distinct groups of humoral immune reactions to papillomavirus antigens in women with squamous intraepithelial lesions.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(3):183-8.
1996: Arthur Schatzkin; Laurence S Freedman; Joanne F Dorgan; L M McShane; Mark Schiffman; Sanford M Dawsey
Surrogate end points in cancer research: a critique.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1996;5(12):947-53.
1996: Louise Wideroff; Mark Schiffman; Robert Hoover; R E Tarone; B Nonnenmacher; N Hubbert; Reinhard Kirnbauer; CE Greer; Attila T Lorincz; M Michele Manos; Andrew G. Glass; David R Scott; Mark E Sherman; J Buckland; Douglas Lowy; J Schiller
Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and-negative women.
The Journal of infectious diseases 1996;174(5):937-43.
1996: T Tsukui; Allan Hildesheim; Mark Schiffman; Joseph Lucci; D Contois; P Lawler; Brenda B Rush; Attila T Lorincz; A Corrigan; Robert D Burk; W Qu; M A Marshall; Dean L Mann; Mary Carrington; M Clerici; G M Shearer; David P Carbone; David R Scott; R A Houghten; Jay A Berzofsky
Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology.
Cancer research 1996;56(17):3967-74.
1996: A W Hsing; Robert D Burk; K L Liaw; C J Chen; T Zhang; Mark Schiffman; CE Greer; S L You; C Y Hsieh; T W Huang; Tzyy-choou Wu; timothy o'leary; J D Seidman; M Michele Manos
Interlaboratory agreement in a polymerase chain reaction-based human papillomavirus DNA assay.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1996;5(6):483-4.
1996: D T Silverman; Mark Schiffman; S Devesa
Diagnostic certainty in pancreatic cancer.
Journal of clinical epidemiology 1996;49(5):601-3.
1996: C Rattray; Howard D Strickler; C Escoffery; Beverley Cranston; C Brown; Angela Manns; Mark Schiffman; Joel Palefsky; Barrie Hanchard; William A Blattner
Type-specific prevalence of human papillomavirus DNA among Jamaican colposcopy patients.
The Journal of infectious diseases 1996;173(3):718-21.
1996: Louise Wideroff; Mark Schiffman; N Hubbert; Reinhard Kirnbauer; J Schiller; C Greer; M Michele Manos; Sanford M Dawsey; Ji-You Li; Louise A Brinton
Serum antibodies to HPV 16 virus-like particles are not associated with penile cancer in Chinese males.
Viral immunology 1996;9(1):23-5.
1995: Louise Wideroff; Mark Schiffman; B Nonnenmacher; N Hubbert; Reinhard Kirnbauer; CE Greer; Douglas Lowy; Attila T Lorincz; M Michele Manos; Andrew G. Glass
Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia.
The Journal of infectious diseases 1995;172(6):1425-30.
1995: Mark Schiffman; Louise A Brinton
The epidemiology of cervical carcinogenesis.
Cancer 1995;76(10 Suppl):1888-901.
1995: Debra T Silverman; Linda Morris Brown; Robert N Hoover; Mark Schiffman; K D Lillemoe; Janet B Schoenberg; G Marie Swanson; R B Hayes; Raymond S Greenberg; J Benichou
Alcohol and pancreatic cancer in blacks and whites in the United States.
Cancer research 1995;55(21):4899-905.
1995: K L Liaw; A W Hsing; C J Chen; Mark Schiffman; T Y Zhang; C Y Hsieh; CE Greer; S L You; T W Huang; Tzyy-choou Wu
Human papillomavirus and cervical neoplasia: a case-control study in Taiwan.
International journal of cancer. Journal international du cancer 1995;62(5):565-71.
1995: F X Bosch; M Michele Manos; N Muñoz; M Sherman; A M Jansen; J Peto; Mark Schiffman; Victor Moreno; Robert J Kurman; Keerti V Shah
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.
Journal of the National Cancer Institute 1995;87(11):796-802.
1995: Howard D Strickler; C Escoffery; C Rattray; D Fuchs; H Wachter; Angela Manns; Mark Schiffman; Beverley Cranston; Barrie Hanchard; William A Blattner
Cervical intraepithelial neoplasia is not associated with elevated serum neopterin levels.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1995;4(3):295-8.
1995: Howard D Strickler; C Rattray; C Escoffery; Angela Manns; Mark Schiffman; C Brown; Beverley Cranston; Barrie Hanchard; Joel Palefsky; William A Blattner
Human T-cell lymphotropic virus type I and severe neoplasia of the cervix in Jamaica.
International journal of cancer. Journal international du cancer 1995;61(1):23-6.
1995: J T Cox; A T Lorincz; Mark Schiffman; M E Sherman; A Cullen; Robert J Kurman
Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.
American journal of obstetrics and gynecology 1995;172(3):946-54.
1995: Mark Schiffman; N B Kiviat; Robert D Burk; Keerti V Shah; Richard W Daniel; R Lewis; Jane Kuypers; M Michele Manos; David R Scott; Mark E Sherman
Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture.
Journal of clinical microbiology 1995;33(3):545-50.
1994: M Michele Manos; J Waldman; T Y Zhang; CE Greer; G Eichinger; Mark Schiffman; Cosette M Wheeler
Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses.
The Journal of infectious diseases 1994;170(5):1096-9.
1994: Debra T Silverman; J A Dunn; Robert N Hoover; Mark Schiffman; K D Lillemoe; Janet B Schoenberg; Linda Morris Brown; Raymond S Greenberg; R B Hayes; G Marie Swanson
Cigarette smoking and pancreas cancer: a case-control study based on direct interviews.
Journal of the National Cancer Institute 1994;86(20):1510-6.
1994: Mark E Sherman; Mark Schiffman; Attila T Lorincz; M Michele Manos; David R Scott; R J Kuman; N B Kiviat; M Stoler; Andrew G. Glass; Brenda B Rush
Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types.
American journal of clinical pathology 1994;102(2):182-7.
1994: A W Hsing; Mark Schiffman; T Zhang; CE Greer; C J Chen; S L You; C Y Hsieh; T W Huang; K L Liaw; M Michele Manos
Persistence of type-specific human papillomavirus infection among cytologically normal women.
The Journal of infectious diseases 1994;170(2):498.
1994: Mark E Sherman; LJ Mango; Deidra Kelly; G Paull; V Ludin; C Copeland; D Solomon; Mark Schiffman
PAPNET analysis of reportedly negative smears preceding the diagnosis of a high-grade squamous intraepithelial lesion or carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1994;7(5):578-81.
1994: Mark Schiffman; Arthur Schatzkin
Test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia.
Cancer research 1994;54(7 Suppl):1944s-1947s.
1994: Allan Hildesheim; Mark Schiffman; Patti Gravitt; Andrew G. Glass; CE Greer; T Zhang; David R Scott; Brenda B Rush; P Lawler; Mark E Sherman
Persistence of type-specific human papillomavirus infection among cytologically normal women.
The Journal of infectious diseases 1994;169(2):235-40.
1994: Mark Schiffman
Epidemiology of cervical human papillomavirus infections.
Current topics in microbiology and immunology 1994;186():55-81.
1994: Howard D Strickler; Joakim Dillner; Mark Schiffman; C Eklund; Andrew G. Glass; C Greer; David R Scott; Mark E Sherman; Robert J Kurman; M Michele Manos
A seroepidemiologic study of HPV infection and incident cervical squamous intraepithelial lesions.
Viral immunology 1994;7(4):169-77.
1993: Allan Hildesheim; Patti Gravitt; Mark Schiffman; Robert J Kurman; W Barnes; S Jones; J G Tchabo; Louise A Brinton; C Copeland; J Epp
Determinants of genital human papillomavirus infection in low-income women in Washington, D.C.
Sexually transmitted diseases 1993;20(5):279-85.
1993: HM Bauer; Allan Hildesheim; Mark Schiffman; Andrew G. Glass; Brenda B Rush; David R Scott; D M Cadell; Robert J Kurman; M Michele Manos
Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon.
Sexually transmitted diseases 1993;20(5):274-8.
1993: Mark Schiffman; HM Bauer; Robert N Hoover; Andrew G. Glass; D M Cadell; Brenda B Rush; David R Scott; Mark E Sherman; Robert J Kurman; Sholom Wacholder
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.
Journal of the National Cancer Institute 1993;85(12):958-64.
1993: Arthur Schatzkin; L Freedman; Mark Schiffman
An epidemiologic perspective on biomarkers.
Journal of internal medicine 1993;233(1):75-9.
1992: J T Cox; Mark Schiffman; A J Winzelberg; J M Patterson
An evaluation of human papillomavirus testing as part of referral to colposcopy clinics.
Obstetrics and gynecology 1992;80(3 Pt 1):389-95.
1992: Mark Schiffman
Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia.
Journal of the National Cancer Institute 1992;84(6):394-8.
1992: L S Freedman; A Schatzkin; Mark Schiffman
Statistical validation of intermediate markers of precancer for use as endpoints in chemoprevention trials.
Journal of cellular biochemistry. Supplement 1992;16G():27-32.
1992: Mark Schiffman
Validation of hybridization assays: correlation of filter in situ, dot blot and PCR with Southern blot.
IARC scientific publications 1992;(119):169-79.
1991: C Ley; HM Bauer; Arthur Reingold; Mark Schiffman; J C Chambers; C J Tashiro; M Michele Manos
Determinants of genital human papillomavirus infection in young women.
Journal of the National Cancer Institute 1991;83(14):997-1003.
1991: C J Jones; Mark Schiffman; Robert J Kurman; P Jacob; N L Benowitz
Elevated nicotine levels in cervical lavages from passive smokers.
American journal of public health 1991;81(3):378-9.
1991: Mark Schiffman; HM Bauer; Attila T Lorincz; M Michele Manos; J C Byrne; Andrew G. Glass; D M Cadell; Peter M Howley
Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA.
Journal of clinical microbiology 1991;29(3):573-7.
1991: Louise A Brinton; Ji-You Li; S D Rong; S Huang; B S Xiao; B G Shi; Z J Zhu; Mark Schiffman; Sanford M Dawsey
Risk factors for penile cancer: results from a case-control study in China.
International journal of cancer. Journal international du cancer 1991;47(4):504-9.
1990: Arthur Schatzkin; Laurence S Freedman; Mark Schiffman; Sanford M Dawsey
Validation of intermediate end points in cancer research.
Journal of the National Cancer Institute 1990;82(22):1746-52.
1990: Arthur Schatzkin; Mark Schiffman; E Lanza
Research priorities in large bowel cancer prevention.
Seminars in oncology 1990;17(4):425-37.
1990: B P Negrini; Mark Schiffman; Robert J Kurman; W Barnes; L Lannom; K Malley; Louise A Brinton; G Delgado; S Jones; J G Tchabo
Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix.
Cancer research 1990;50(15):4670-5.
1990: Rachel Ballard-Barbash; Arthur Schatzkin; Demetrius Albanes; Mark Schiffman; Bernard E Kreger; W B Kannel; K M Anderson; W E Helsel
Physical activity and risk of large bowel cancer in the Framingham Study.
Cancer research 1990;50(12):3610-3.
1990: A T Lorincz; Mark Schiffman; W J Jaffurs; J Marlow; A P Quinn; G F Temple
Temporal associations of human papillomavirus infection with cervical cytologic abnormalities.
American journal of obstetrics and gynecology 1990;162(3):645-51.
1989: Patricia Hartge; Mark Schiffman; Robert Hoover; Larry McGowan; L Lesher; H J Norris
A case-control study of epithelial ovarian cancer.
American journal of obstetrics and gynecology 1989;161(1):10-6.
1989: Mark Schiffman; A W Andrews; R L Van Tassell; L Smith; J Daniel; A Robinson; Robert N Hoover; J Rosenthal; R Weil; P P Nair
Case-control study of colorectal cancer and fecal mutagenicity.
Cancer research 1989;49(12):3420-4.
1989: Mark Schiffman; Patricia Hartge; R N Hoover; Larry McGowan; L Lesher; H J Norris
Epithelial ovarian cancer.
Gynecologic oncology 1989;33(1):129-32.
1989: Mark Schiffman; R L Van Tassell; A W Andrews; S Wacholder; J Daniel; A Robinson; L Smith; P P Nair; T D Wilkins
Fecapentaene concentration and mutagenicity in 718 North American stool samples.
Mutation research 1989;222(4):351-7.
1989: Mark Schiffman; R L Van Tassell; A Robinson; L Smith; J Daniel; Robert N Hoover; R Weil; J Rosenthal; P P Nair; S Schwartz
Case-control study of colorectal cancer and fecapentaene excretion.
Cancer research 1989;49(5):1322-6.
1988: Robert J Kurman; Mark Schiffman; Wayne D Lancaster; R Reid; A Bennett Jenson; G F Temple; A T Lorincz
Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression.
American journal of obstetrics and gynecology 1988;159(2):293-6.
1988: Mark Schiffman; Linda Pickle; Elizabeth T H Fontham; Shelia Hoar Zahm; R Falk; J Mele; P Correa; Joseph Fraumeni
Case-control study of diet and mesothelioma in Louisiana.
Cancer research 1988;48(10):2911-5.
1988: Mark Schiffman; P Bitterman; A L Viciana; Catherine Schairer; L Russell; R L Van Tassell; T D Wilkins
Fecapentaenes and their precursors throughout the bowel--results of an autopsy study.
Mutation research 1988;208(1):9-15.
1987: Mark Schiffman; Louise A Brinton; E Holly; L Lannom; Robert J Kurman; Wayne D Lancaster; A W Andrews; J Felton
Regarding mutagenic mucus in the cervix of smokers.
Journal of the National Cancer Institute 1987;78(3):590-1.
1985: Mark Schiffman; Patricia Hartge; L P Lesher; Larry McGowan
Mumps and postmenopausal ovarian cancer.
American journal of obstetrics and gynecology 1985;152(1):116-8.